1. Wang, Heping, Pu, Shanrui, Xu, Haitao, Huang, Xiaobin, Pu, Jun. 2023. BTN2A2, a new biomarker and therapeutic target for glioma. In Aging, 15, 10996-11011. doi:10.18632/aging.205039. https://pubmed.ncbi.nlm.nih.gov/37851374/
2. Huang, Youjiao, Han, Feng, Li, Jiaju, Su, Min, Hu, Rong. 2023. BTN2A2-Ig protein inhibits the differentiation of pathogenic Th17 cells and attenuates EAE in mice. In Immunology letters, 260, 58-67. doi:10.1016/j.imlet.2023.06.009. https://pubmed.ncbi.nlm.nih.gov/37369312/
3. Kim, Jae Woong, Rim, Doeun, Ann, Chang Hyeok, Lee, Sug Hyung. 2023. Frameshift mutations of immunomodulatory BTN2A1, BTN2A2, and BTNL3 genes in colon cancers. In Pathology, research and practice, 249, 154769. doi:10.1016/j.prp.2023.154769. https://pubmed.ncbi.nlm.nih.gov/37634314/
4. Frech, Michael, Schuster, Gregor, Andes, Fabian T, Zaiss, Mario M, Sarter, Kerstin. 2021. RANKL-Induced Btn2a2 - A T Cell Immunomodulatory Molecule - During Osteoclast Differentiation Fine-Tunes Bone Resorption. In Frontiers in endocrinology, 12, 685060. doi:10.3389/fendo.2021.685060. https://pubmed.ncbi.nlm.nih.gov/34421818/
5. Zhu, Hong, Xia, Wei, Mo, Xing-Bo, Deng, Fei-Yan, Lei, Shu-Feng. 2016. Gene-Based Genome-Wide Association Analysis in European and Asian Populations Identified Novel Genes for Rheumatoid Arthritis. In PloS one, 11, e0167212. doi:10.1371/journal.pone.0167212. https://pubmed.ncbi.nlm.nih.gov/27898717/
6. Smith, Isobel A, Knezevic, Brittany R, Ammann, Johannes U, Mather, Ian H, Trowsdale, John. 2010. BTN1A1, the mammary gland butyrophilin, and BTN2A2 are both inhibitors of T cell activation. In Journal of immunology (Baltimore, Md. : 1950), 184, 3514-25. doi:10.4049/jimmunol.0900416. https://pubmed.ncbi.nlm.nih.gov/20208008/